Zenith Alpha、Excluder与Endurant腔内修复肾下腹主动脉瘤后肢体移植物闭塞的多中心队列研究
这项多中心回顾性队列研究纳入2012–2018年五个瑞典中心924例标准EVAR患者,比较三种覆膜支架的肢体移植物闭塞(LGO)发生率。中位随访37个月,LGO总发生率5.9%,Zenith Alpha为12.4%、Excluder为0.7%、Endurant为3.3%。嵌套病例对照分析显示Zenith Alpha、髂外动脉锚定区及髂外动脉直径<10 mm与LGO风险升高相关。
要点
- Zenith Alpha支架LGO发生率为12.4%,明显高于Excluder(0.7%)和Endurant(3.3%)。
- Zenith Alpha装置与LGO风险升高独立相关(OR 5.31,95%CI 1.97–14.3)。
- 髂外动脉锚定(OR 5.91)和髂外动脉直径<10 mm(OR 4.99)也是LGO危险因素。
核心结论
- 覆膜支架装置类型是EVAR术后肢体移植物闭塞的独立危险因素。
- Zenith Alpha相比Endurant和Excluder装置LGO风险升高。
- 髂外动脉锚定区和髂外动脉直径<10 mm也是LGO的危险因素。
研究设计与样本
- 多中心回顾性队列研究,纳入五个瑞典血管外科中心2012年1月至2018年12月因肾下腹主动脉瘤行标准EVAR作为主要干预的全部患者。
- 共纳入924例患者,男性84%,平均年龄76岁(±7.5 SD),AAA中位直径59 mm(IQR 55, 67)。
- 采用嵌套病例对照设计,按1:3发生率密度抽样分析围手术期和形态学危险因素,条件逻辑回归估计多变量OR及95%CI。
主要发现
- 中位随访37个月(IQR 21, 62),共发生55例闭塞(5.9%)。
- Zenith Alpha组39例闭塞(12.4%),Excluder组1例(0.7%),Endurant组15例(3.3%)。
- 嵌套病例对照分析中,Zenith Alpha装置OR 5.31(95%CI 1.97–14.3),髂外动脉锚定OR 5.91(95%CI 1.30–26.7),髂外动脉直径<10 mm OR 4.99(95%CI 1.46–16.9)。
关键数值与推荐
- LGO定义为无症状的肢体完全闭塞或接受治疗的重度狭窄。
- Zenith Alpha组使用ZISL肢体,Excluder组使用PLC/PXC肢体,Endurant组使用ETLW/ETEW肢体。
临床怎么用
- 选择EVAR覆膜支架时应考虑装置类型对LGO风险的影响,Zenith Alpha需警惕。
- 术前评估髂外动脉直径和锚定区,髂外动脉<10 mm或锚定于髂外动脉时LGO风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Limb graft occlusion (LGO) is a serious complication after endovascular aneurysm repair (EVAR) and while device development enables treatment of increasingly complex aortic anatomy, little is known about how endograft type affects the risk of occlusion. This observational study aimed to explore the incidence of LGO after EVAR for three major endograft systems. METHODS: All patients with standard EVAR as the primary intervention for infrarenal abdominal aortic aneurysm (AAA), between January 2012 and December 2018, at five Swedish vascular surgery centres, were included in this multicentre retrospective cohort study. LGO was defined as a total limb occlusion regardless of symptoms, or a treated significant stenosis. A nested case control (NCC) design with incidence density sampling of 1:3 was used for analysis of potential per-operative and morphological risk factors. Conditional logistic regression was used to estimate multivariable odds ratios (OR) with 95% confidence intervals (CI) RESULTS: A total of 924 patients were included. The majority were male (84%), the mean age was 76 years (± 7.5 SD), and median AAA diameter was 59 mm (IQR 55, 67). Patients were treated with Zenith Alpha (n = 315, ZISL limbs), Excluder (n = 152, PLC/PXC limbs), and Endurant (n = 457, ETLW/ ETEW limbs). During median follow up of 37 months (IQR 21, 62), 55 occlusions occurred (5.9%); 39 with Zenith Alpha (12.4%), one with Excluder (0.7%), and 15 with Endurant (3.3%). In the NCC analysis, the Zenith Alpha device (OR 5.31, 95% CI 1.97 - 14.3), external iliac artery (EIA) landing (OR 5.91, 95% CI 1.30 - 26.7), and EIA diameter < 10 mm (OR 4.99, 95% CI 1.46 - 16.9) were associated with an increased risk of LGO. CONCLUSION: Endograft device type is an independent risk factor for LGO after EVAR. Specifically, the Zenith Alpha demonstrated an increased risk of LGO compared with the Endurant and Excluder devices. In addition, a narrow EIA and landing zone in EIA are also risk factors for LGO.
引用
- Bogdanovic M, Stackelberg O, Lindström D, et al. Limb Graft Occlusion Following Endovascular Aneurysm Repair for Infrarenal Abdominal Aortic Aneurysm with the Zenith Alpha, Excluder, and Endurant Devices: a Multicentre Cohort Study. Eur J Vasc Endovasc Surg. 2021. PMID: 34266764. doi:10.1016/j.ejvs.2021.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。